Marie Payton
Chief Tech/Sci/R&D Officer presso LOGICBIO THERAPEUTICS, INC.
Profilo
Marie Payton is currently the VP-Clinical Development Operations at LogicBio Therapeutics, Inc. She previously worked as the Senior Director-Clinical Operations at Aileron Therapeutics, Inc. She received an undergraduate degree from the University of Massachusetts and an MBA from F.W.
Olin Graduate School of Business.
Posizioni attive di Marie Payton
| Società | Posizione | Inizio |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/04/2019 |
Precedenti posizioni note di Marie Payton
| Società | Posizione | Fine |
|---|---|---|
| AILERON THERAPEUTICS, INC. | Chief Operating Officer | - |
Formazione di Marie Payton
| University of Massachusetts | Undergraduate Degree |
| F.W. Olin Graduate School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AILERON THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
- Borsa valori
- Insiders
- Marie Payton
